- Round ID
- FR-00473
- Stage
- Growth round (aggregators label this 'Series D')
- Round name
- Growth round (aggregators label this 'Series D')
- Amount
- £25M (reported as $32.6-32.7M)
Dated funding evidence
OrganOx
Growth round (aggregators label this 'Series D') · £25M (reported as $32.6-32.7M) · 2023-07-17
Reported round£25M (reported as $32.6-32.7M)Growth round (aggregators label this 'Series D')
- Disclosure date
- 2023-07-17
- Reported currency
- GBP
- Companies House
- 06557113
- Evidence sources
- 1
Company
OrganOxCH 065571132023-07-17Growth round (aggregators label this 'Series D')£25M (reported as $32.6-32.7M)
Resolved investor records
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Lauxera Capital Partners
- Other investors
- Existing investors (not individually named in the release)
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-10-08
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.